e-Drug3D

2096

M MOMELOTINIB

INN
MOMELOTINIB

cas 1841094-23-2

CLASS

ANTINEOPLASTIC
TREATMENT OF MYELOFIBROSIS
JANUS KINASE 1 AND 2 (JAK1/JAK2) INHIBITOR AND AND MUTANT JAK2V617F

ROUTE (list)

PK parameters

t1/2 6 HOUR

Target

TARGET JANUS KINASE 1 AND 2 (JAK1/JAK2)

Download SDF file

Benzamide, N-(cyanomethyl)-4-[2-[[4-(3-oxo-4-morpholinyl)phenyl]amino]-4-pyrimidinyl]- (ACI)

Formula:
C23H20N6O3

Calculated chemical properties:

MW 428.45
NB_atoms 32
XLogP 2.50
PSA 106.562
NB_HD 2
NB_HA 9
fsp3 0.17
Lipinski(0=no;1=yes) 1

FDA
-